Smiths Medical Recalls Certain CADD System Administration Sets and Cassette Reservoirs for Issues Causing Delay, Interruption, or Under-Delivery of Therapy
Smiths Medical is recalling certain CADD Administration Sets and Medication Cassette Reservoirs, used with the CADD ambulatory infusion system, for two issues: a risk of tubing occlusion and a risk of false “No Disposable Attached (NDA)” alarms. Either of these issues can cause delay of therapy, interruption 12 Drug News – Volume 10, Issue 2
of therapy, or under-delivery of medication, which all have the potential to cause serious patient harm or death.
The U.S. Food and Drug Administration (FDA) has identified this as a Class I recall, the most serious type of recall.
